JPMorgan's Fremont factory survey confirms Tesla's Robotaxi expansion is locked to FSD v15, with Optimus commercial sales targeted for 2027.
JPMorgan's Fremont factory survey confirms Tesla's Robotaxi expansion is locked to FSD v15, with Optimus commercial sales targeted for 2027.

JPMorgan's on-site survey of Tesla's Fremont factory found the Robotaxi fleet's next expansion point is tied directly to FSD v15, with about 40 percent of the software's seven core modules already running on test vehicles.
"The next meaningful deployment inflection for the Robotaxi fleet is directly tied to the launch of FSD v15," JPMorgan analysts wrote after touring the plant and meeting Tesla's investor relations team.
The bank kept a Neutral rating and $445 price target, versus the stock at $339.30. Tesla said it is deliberately limiting how many Model Ys it converts to robotaxis because it is confident the purpose-built Cybercab can scale soon, and it is installing the Optimus production line on the site of the Model S/X line retired in May.
Robotaxi and Optimus are the two growth narratives underpinning Tesla's valuation. JPMorgan expects fleet expansion to accelerate from late 2026 into early 2027, while Optimus commercial sales could begin as early as the second half of 2027.
Tesla framed v15 as a step-change comparable to the v13-to-v14 jump, which brought a large increase in parameters, a wider context window and about 20 percent lower latency. The current AI4/HW4 hardware stack can already run v15 and support unsupervised FSD, while the coming AI4.5 system adds roughly 10 percent more compute and about double the memory to handle larger models.
The unit economics are the core of the pitch. Tesla said Model Y and Model 3 cost $0.60 to $0.70 per mile under personal use, falling to $0.50 to $0.60 per mile at robotaxi utilization rates four to five times higher — well below the $2.50 to $3.00 per mile that ride-hail platforms charge. The long-term target is about $0.30 per mile on a dedicated robotaxi platform, with Cybercab only the first of several vehicles.
Optimus Gen 3's design is finalized and its supply chain largely locked, though Tesla is holding back the reveal until closer to start of production to protect its edge. The rollout runs in three stages: deployment to an "Optimus Academy" in the second half of 2026 for real-world data collection, then internal factory use, then external commercial sales as early as the second half of 2027. Stamping and body-in-white are the most likely first applications because they are repetitive and hazardous, while final assembly — still dependent on human dexterity — is a longer-term target. Fremont's long-run capacity is about 1 million units, versus about 10 million at the Texas plant.
FSD is increasingly a purchase decision, with Tesla noting demand jumps in Australia, South Korea and early European markets after the software launched. The company ended one-time purchases in the U.S. and Canada in February and will complete the global shift to a roughly $99 monthly subscription by August, betting that high renewal rates follow the free trial offered to new owners. In Europe, Tesla is pursuing a dual-track approval with the EU and individual members such as the Netherlands, citing about 65 million kilometers of driving data showing collision events down about fivefold.
The survey lands as Tesla prepares to launch the Cybercab to the public in Austin as soon as this month, according to The Information. That puts it in direct competition with Waymo, which has logged more than 220 million fully driverless miles versus Tesla's roughly 380,000, and Amazon's Zoox, which is expanding fully driverless service to San Francisco and Las Vegas. Tesla shares, down about 22 percent year to date, trade with only 44 percent of analysts bullish, and JPMorgan's $445 target implies limited near-term upside. The bank's 2026 delivery estimate of about 1.8 million units sits well below Tesla's roughly 3 million capacity ceiling, leaving room for the demand recovery to surprise.
This article is for informational purposes only and does not constitute investment advice.